The University of Chicago Header Logo

Connection

Philip Charles Hoffman to Injections, Subcutaneous

Back to Details
This is a "connection" page, showing publications Philip Charles Hoffman has written about Injections, Subcutaneous.
Philip Charles Hoffman
Connection Strength
0.009
Injections, Subcutaneous
  1. Phase I study of treatment with oral 13-cis-retinoic acid, subcutaneous interferon alfa-2a, cisplatin, and 24-hour infusion 5-fluorouracil/leucovorin. Cancer Chemother Pharmacol. 1997; 39(3):227-32.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.